Funded Tech Companies
Adagio Therapeutics
Adagio Therapeutics is a leading biopharmaceutical company, based in Waltham. Financial backing was provided by Adimab, Fidelity Management & Research Company and GV.
Company Overview
Company Name
Adagio Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
303 Wyman St. 300
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses. We believe our antibodies will match or exceed the potency and coverage of conventional SARS-CoV-2 antibody programs, and can be used as both therapeutic and durable prophylactic treatments.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
8/6/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tillman Gerngross
Chief Financial Officer
Jane Henderson
Chief Medical Officer
Lynn Connolly
Chief Operating Officer
Halley Gilbert
Chief Scientific Officer
Laura Walker
Chief Technical Officer
Becky Dabora
VP - Bus. Development
Ellie Hershberger
VP - Bus. Development
Eric Kimble
Company Investors
- Adimab
- Fidelity Management & Research Company
- GV
- OrbiMed
- Polaris Partners (Terry McGuire)
- Omega Funds
- Premji Invest
- Foresite Capital
- Mithril Capital Management (Ajay Royan)
- RA Capital
- Population Health Partners
- Redmile Group
- ArrowMark Partners
- Federated Kaufmann Funds
- Partners HealthCare System
- M28 Capital (Marc Elia)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs